MUHAMMAD ALAM: Open Payments
NPI 1750558979 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 7 companies in 2025. Trend: 2023 $235 · 2024 $167 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| ABBVIE INC. | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, VRAYLAR, Vanflyta, ARISTADA, FANAPT, UZEDY, REXULTI.
Industry payments across GA — which companies pay providers there.
